These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1447 related items for PubMed ID: 18022071

  • 1. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM, Jabbour A, Weintraub R, Brown K, Hayward CS, Macdonald PS.
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
    Gomberg-Maitland M, McLaughlin V, Gulati M, Rich S.
    Am J Cardiol; 2005 Nov 01; 96(9):1334-6. PubMed ID: 16253609
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
    Benza RL, Seeger W, McLaughlin VV, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubin LJ.
    J Heart Lung Transplant; 2011 Dec 01; 30(12):1327-33. PubMed ID: 22055098
    [Abstract] [Full Text] [Related]

  • 6. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N, Sharma MK, Sinha N.
    Int J Cardiol; 2007 Sep 03; 120(3):306-13. PubMed ID: 17174417
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL.
    Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].
    Xiong CM, He JG, Lu XL, Shan GL, Wu BX, Zhu XY, Wu GH, Zeng XF, Guo T, Liu ZH, Ni XH, Cheng XS, Gu Q, Zhao ZH, Tian HY, Li WM, Zhang DZ, Zhang C, Li MT, Liu HM, Guo YJ, Shen JY, Zhang WJ, Liu S, Zhou DX, Bao CD, Huang SA, Chen JY, Wu WF, Huang K, Li CL, Wang LH, He B.
    Zhonghua Yi Xue Za Zhi; 2011 Feb 15; 91(6):370-4. PubMed ID: 21418907
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ, Escribano P, Delgado JF, Jiménez C, Tello R, Gómez MA, de la Calzada CS.
    J Heart Lung Transplant; 2006 Nov 15; 25(11):1353-7. PubMed ID: 17097500
    [Abstract] [Full Text] [Related]

  • 14. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP, Rohit M, Grover A, Malhotra S, Vijayvergiya R.
    Am Heart J; 2006 Apr 15; 151(4):851.e1-5. PubMed ID: 16569546
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R, Reichenberger F, Enke B, Kreckel A, Krick S, Gall H, Schermuly RT, Grimminger F, Rubin LJ, Olschewski H, Seeger W, Ghofrani HA.
    Pulm Pharmacol Ther; 2008 Oct 15; 21(5):824-32. PubMed ID: 18657627
    [Abstract] [Full Text] [Related]

  • 16. [Sildenafil therapy for pulmonary hypertension: a prospective study].
    Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Cheng XS, Gu Q, Zhao ZH, Zeng WJ, Zhu F, He JG.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun 15; 34(6):419-23. PubMed ID: 21781512
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ, Jing ZC, Zhang JH, Wu Y, Wang Y, Jiang X, Wang ZX, Sun YG, Pu JL, Yang YJ.
    Hypertens Res; 2009 Oct 15; 32(10):911-5. PubMed ID: 19644505
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
    Benza RL, Gomberg-Maitland M, Naeije R, Arneson CP, Lang IM.
    J Heart Lung Transplant; 2011 Sep 15; 30(9):982-9. PubMed ID: 21531577
    [Abstract] [Full Text] [Related]

  • 20. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB, PACES Study Group.
    Ann Intern Med; 2008 Oct 21; 149(8):521-30. PubMed ID: 18936500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.